Australia
MINJUVI® (tafasitamab) for Relapsed or Refractory Follicular Lymphoma Approved in Australia
* Minjuvi® (tafasitamab), in combination with rituximab and lenalidomide, is the first and only chemotherapy-free CD19 and CD20 dual-targeted immunotherapy combination regimen to be approved in Australia for adults with relapsed or refractory follicular lymphoma (R/R FL) (Grade 1-3a).1,2 * De...
2026-04-23 15:00
2321
Proudly Human announces Manager Tools as the world's first officially certified podcast as the world struggles to distinguish between AI-generated and human-created content
SYDNEY, April 22, 2026 /PRNewswire/ -- Proudly Human has announced its
certification of all content from global company Manager Tools
2026-04-22 20:32
2443
TeamHive Launches Free Team Effectiveness Indicator, Giving Any Leader or Team Member Instant, Research-Backed Insight Into How Their Team Really Works
HR tech platform, validated by the University of Newcastle, makes its PLUS
model diagnostic available at no cost to teams worldwide
SYDNEY, April 21, 2026 /PRNewswire/ -- TeamHive (https://team-hive.co/
2026-04-22 03:15
2566
Seeing Machines Releases Part 2 of Technical Paper Series on Intoxication
Driver Monitoring System technology enables real-time assessment of a driver's functional state relative to the driving environment CANBERRA, Australia, April 21, 2026 /PRNewswire/ -- Seeing Machines Limited, a global leader in vision-based monitoring technology, has released the second part of ...
2026-04-21 14:00
2248
Kazia Therapeutics Strengthens Scientific Leadership with Appointment of Dr. Sudha Rao as Chief Scientific Officer to Lead Next-Generation Oncology Platform
SYDNEY, April 15, 2026 /PRNewswire/ -- Kazia Therapeutics (NASDAQ: KZIA), a clinical-stage oncology company developing differentiated therapies for cancers with high unmet need, today announced the appointment of Dr. Sudha Rao as Chief Scientific Officer (CSO). Dr. Rao is the scientific originat...
2026-04-15 20:00
5332
Clarity signs a Commercial Manufacturing Agreement for Cu-64 SAR-bisPSMA with Nucleus RadioPharma
SYDNEY, April 14, 2026 /PRNewswire/ -- Clarity Pharmaceuticals (ASX: CU6) ("Clarity" or "Company"), a clinical-stage radiopharmaceutical company with a mission to develop next-generation products that improve treatment outcomes for patients with cancer, is pleased to announce the signing of a Com...
2026-04-14 21:02
3627
Earendil Labs Announces First Patient Dosed in a Phase IIa Trial of a Half-life Extended Anti-TL1A Antibody (HXN-1001) in Patients with Ulcerative Colitis
WILMINGTON, Del., April 2, 2026 /PRNewswire/ -- Earendil Labs, an AI-driven biotechnology company advancing next-generation biologics, today announced the first patient has been dosed in a Phase IIa clinical trial of HXN-1001, a half-life extended anti-TL1A antibody, in patients with ulcerative c...
2026-04-02 19:00
4464
Clarity signs a large-scale Manufacturing Supply Agreement for copper-64 with Theragenics
SYDNEY, March 25, 2026 /PRNewswire/ -- Clarity Pharmaceuticals (ASX: CU6) ("Clarity" or "Company"), a clinical-stage radiopharmaceutical company with a mission to develop next-generation products that improve treatment outcomes for patients with cancer, is pleased to announce the signing of a lar...
2026-03-25 21:01
4921
Breaking the Design Barrier: X-Design Evolves into Zawa, Launching a Dedicated Creative AI Agent for Branding
From "democratizing design" to "systematizing growth," Zawa's new "Zero to Wow" philosophy redefines the future of visual automation for SMBs and local merchants. SYDNEY, March 18, 2026 /PRNewswire/ -- X-Design, the pioneering platform that made professional design accessible to everyone, today ...
2026-03-19 03:39
4694
Co-PSMA data presented at EAU Annual Congress 2026 with manuscript accepted for publication in the European Urology journal
HIGHLIGHTS
* Oral presentation on key results from the Co-PSMA (NCT06907641
2026-03-17 21:01
5568
Trial to test mild hyperbaric oxygen therapy during active treatment for aggressive brain cancer
LISMORE, Australia, March 15, 2026 /PRNewswire/ -- Australian researchers from Southern Cross University (SCU) and the Melbourne Integrative Oncology Group (MIOG) will launch a clinical study investigating whether hyperbaric oxygen therapy (HBOT) can safely support patients undergoing treatment f...
2026-03-16 09:43
3119
Vmake Video Enhancer Introduces "AI 4K+": Setting a New Standard in AI Video Enhancement
SYDNEY, March 10, 2026 /PRNewswire/ -- Vmake recently announced a major upgrade
to VmakeVideo Enhancer
2026-03-11 01:00
4240
Registrational Phase III AMPLIFY trial: Target number of participants achieved
SYDNEY, March 10, 2026 /PRNewswire/ -- Clarity Pharmaceuticals (ASX: CU6) ("Clarity" or "Company"), a clinical-stage radiopharmaceutical company with a mission to develop next-generation products that improve treatment outcomes for patients with cancer, is pleased to announce that the Phase III A...
2026-03-10 21:02
6031
Faybl launches in US, offering RIAs chance to shape the future of AI-powered advice
* Faybl delivers proven efficiency gains of up to 70 percent in support of US advice industry that is struggling for capacity * Faybl has grown Australian user base by 50 percent; already testing V2 in home market * Anthony Lipp announced as new Adviser * Faybl's leadership team will be at...
2026-03-10 20:00
4218
Westpac to change the format of its long-term USD funding
SYDNEY, March 5, 2026 /PRNewswire/ -- Westpac Banking Corporation ("Westpac") today announced its intention to voluntarily deregister from the United States Securities and Exchange Commission (the "SEC") by filing a Form 15F with the SEC as early asMay 2026. Upon filing the Form 15F, Westpac's re...
2026-03-06 01:59
Firmable Raises $14m Series A to Take AI-Native Sales Platform Global
MELBOURNE, Australia, March 2, 2026 /PRNewswire/ -- Firmable, Asia-Pacific's leading AI (artificial intelligence) sales platform, has raised$14 million in Series A funding led by Airtree, with participation from existing investors. The funding will support Firmable's expansion tothe United States...
2026-03-03 00:30
5786
Neurizon Initiates Dosing of NUZ-001 in HEALEY ALS Platform Trial
Highlights: * First participant enrolled and dosed with NUZ-001 in Regimen I of the HEALEY ALS Platform Trial evaluating NUZ-001 for the treatment of ALS * Approximately 160 participants with ALS will be enrolled in a 36-week randomised,double-blind, placebo-controlled adaptive Phase 2/3 clin...
2026-02-27 04:34
7141
GTM.io Launches Operating Partner Model to Close the Go-to-Market Execution Gap
Built for scaling B2B technology companies seeking stronger pipeline, more
consistent revenue execution and sustainable customer expansion.
SYDNEY, Feb. 25, 2026 /PRNewswire/ -- GTM.io
2026-02-26 04:00
4103
Co-PSMA: Cu-64 SAR-bisPSMA more than doubled prostate cancer lesion and patient detection vs. Ga-68 PSMA-11 in head-to-head trial
HIGHLIGHTS * Abstract outlining key findings from the Co-PSMA Investigator-Initiated Trial (IIT) has been released. * The study was led by Prof Louise Emmett at St Vincent's Hospital Sydney, and the abstract was accepted for oral presentation at the upcoming European Association of Urology (...
2026-02-16 22:03
9542
Delonix Bioworks Announces IND Clearance for DX-104, a Novel Engineered MenB OMV Vaccine Candidate, in China and Australia
SHANGHAI, Feb. 6, 2026 /PRNewswire/ -- Delonix Bioworks, a clinical-stage biotechnology company developing next-generation bacterial vaccines,recently announced that its Group B meningococcal (MenB) vaccine candidate, DX-104, has received Investigational New Drug (IND) clearance fromChina's Natio...
2026-02-06 20:00
7162
Week's Top Stories
Most Reposted
HKBU Symphony Orchestra Annual Gala Concert to integrate digital technology and artificial intelligence
[Picked up by 304 media titles]
2026-04-27 21:47
Amadeus outlines intention to acquire Idemia Public Security (IPS) for €1.2 billion, to create seamless end-to-end travel journeys of the future
[Picked up by 300 media titles]
2026-04-29 14:31Agoda and TPO Launch MOU to Unlock Opportunities at the City Level
[Picked up by 292 media titles]
2026-04-28 11:00
DayOne Launches Inaugural Tech & AI Career Expo in Thailand, Showcasing Commitment to Digital Infrastructure and Talent Development
[Picked up by 288 media titles]
2026-04-25 23:06
Hong Leong Bank Vietnam Named Best SME Bank for Customer Experience in Southeast Asia and Vietnam
[Picked up by 288 media titles]
2026-04-28 17:50
Most Read
DayOne Launches Inaugural Tech & AI Career Expo in Thailand, Showcasing Commitment to Digital Infrastructure and Talent Development
2026-04-25 23:06
5330
HKBU Symphony Orchestra Annual Gala Concert to integrate digital technology and artificial intelligence
2026-04-27 21:47
5004
Madame Tussauds Hong Kong Celebrates the Arrival of Two Major Chinese Superstars: Hua Chenyu and Luo Yunxi's Permanent Wax Figures
2026-04-27 10:00
4895
NYSE Content Update: AI Company Vast Data Announces $30 Billion Valuation
2026-04-25 00:33
4723
